Mylan launches generic version of Faslodex Injection to treat breast cancer Medical Dialogues Bureau19 Sep 2019 4:05 AM GMTNew Delhi: Mylan N.V. recently announced the U.S. launch of Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per single-dose prefilled syringe, a generic...